These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20801077)

  • 1. Differential resistance to antiviral drugs in an immunocompromised patient with cytomegalovirus encephalitis.
    Wada T; Mase S; Shibata F; Shimizu M; Toma T; Yachie A
    J Clin Virol; 2010 Nov; 49(3):223-4. PubMed ID: 20801077
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein kinase) and UL54 (DNA polymerase) mutations.
    Scott GM; Isaacs MA; Zeng F; Kesson AM; Rawlinson WD
    J Med Virol; 2004 Sep; 74(1):85-93. PubMed ID: 15258973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus ventriculoencephalitis in a peripheral blood stem cell transplant recipient.
    Miller GG; Boivin G; Dummer JS; McConnell T; Becher MW; Kassim A; Tang YW
    Clin Infect Dis; 2006 Feb; 42(4):e26-9. PubMed ID: 16421783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid detection of human cytomegalovirus UL97 and UL54 mutations for antiviral resistance in clinical specimens.
    Daikoku T; Saito K; Aihara T; Ikeda M; Takahashi Y; Hosoi H; Nishida T; Takemoto M; Shiraki K
    Microbiol Immunol; 2013 May; 57(5):396-9. PubMed ID: 23668613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrasting effects on ganciclovir susceptibility and replicative capacity of two mutations at codon 466 of the human cytomegalovirus UL97 gene.
    Martin M; Goyette N; Boivin G
    J Clin Virol; 2010 Dec; 49(4):296-8. PubMed ID: 20843736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanism of drug-resistance in human cytomegalovirus].
    Eizuru Y
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():476-9. PubMed ID: 17455666
    [No Abstract]   [Full Text] [Related]  

  • 7. [Strains of ganciclovir-resistant cytomegalovirus].
    Calicó I; García E; Cortés A; Gavaldá J; Roman A; Valle I
    Enferm Infecc Microbiol Clin; 1999; 17(7):330-4. PubMed ID: 10535184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus UL97 mutations associated with ganciclovir resistance in immunocompromised patients from Argentina.
    Sánchez Puch S; Ochoa C; Carballal G; Zala C; Cahn P; Brunet R; Salomón H; Videla C
    J Clin Virol; 2004 Jul; 30(3):271-5. PubMed ID: 15135748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of drug-resistant human cytomegalovirus].
    Murayama T
    Nihon Rinsho; 2006 Mar; 64 Suppl 3():508-11. PubMed ID: 16615525
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiviral drug resistance in human cytomegalovirus.
    Chou S
    Transpl Infect Dis; 1999 Jun; 1(2):105-14. PubMed ID: 11428978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive restriction analysis of the UL97 region allows early detection of ganciclovir-resistant human cytomegalovirus in an immunocompromised child.
    Prix L; Hamprecht K; Holzhüter B; Handgretinger R; Klingebiel T; Jahn G
    J Infect Dis; 1999 Aug; 180(2):491-5. PubMed ID: 10395867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus UL97 kinase mutations that confer maribavir resistance.
    Chou S; Wechel LC; Marousek GI
    J Infect Dis; 2007 Jul; 196(1):91-4. PubMed ID: 17538888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus ventriculoencephalitis with compartmentalization of antiviral-resistant cytomegalovirus in a T cell-depleted haploidentical peripheral blood stem cell transplant recipient.
    Jeong TD; Sung H; Choi SH; Lee SO; Yoon HK; Kim MN; Im HJ
    Diagn Microbiol Infect Dis; 2012 Nov; 74(3):307-10. PubMed ID: 22921815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genetic basis of human cytomegalovirus resistance and current trends in antiviral resistance analysis.
    James SH; Prichard MN
    Infect Disord Drug Targets; 2011 Oct; 11(5):504-13. PubMed ID: 21827431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of cytomegalovirus drug resistance mutations by next-generation sequencing.
    Sahoo MK; Lefterova MI; Yamamoto F; Waggoner JJ; Chou S; Holmes SP; Anderson MW; Pinsky BA
    J Clin Microbiol; 2013 Nov; 51(11):3700-10. PubMed ID: 23985916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus resistance testing: pitfalls and problems for the clinician.
    Drew WL
    Clin Infect Dis; 2010 Mar; 50(5):733-6. PubMed ID: 20100090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients.
    Nogueira E; Ozaki KS; Tomiyama H; Granato CF; Camara NO; Pacheco-Silva A
    Int Immunopharmacol; 2006 Dec; 6(13-14):2031-7. PubMed ID: 17161359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human cytomegalovirus antiviral drug resistance in hematopoietic stem cell transplantation: current state of the art.
    Campos AB; Ribeiro J; Boutolleau D; Sousa H
    Rev Med Virol; 2016 May; 26(3):161-82. PubMed ID: 26990717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel DNA polymerase mutations conferring cytomegalovirus resistance: input of BAC-recombinant phenotyping and 3D model.
    Hantz S; Cotin S; Borst E; Couvreux A; Salmier A; Garrigue I; Merville P; Mengelle C; Attal M; Messerle M; Alain S
    Antiviral Res; 2013 Apr; 98(1):130-4. PubMed ID: 23415883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of antiviral drug resistance in untreated patients with cytomegalovirus retinitis.
    Liu W; Shum C; Martin DF; Kuppermann BD; Hall AJ; Margolis TP
    J Infect Dis; 2000 Oct; 182(4):1234-8. PubMed ID: 10979924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.